Katy Beckermann: Nectin-4 Strategy Discussion by Andrea Apolo Centers on Payload in Urothelial Cancer

Andrea Apolo
Get notified whenever this star has news
What happened to Andrea Apolo today?
No new stories today yet — we check every few minutes.
Browse by day
Who is this?
Andrea B. Apolo is an American medical oncologist specialized in bladder cancer research. She is an investigator in the National Cancer Institute's genitourinary malignancies branch and head of the bladder cancer section.
What happened recently
Andrea Apolo: Several accruing Clinical Trials for patients with Small Cell Bladder Cancer
Bridging Evidence to Practice: Bladder Cancer Therapy Guidelines and Global Implementation
Andrea B. Apolo, MD, on Urothelial Carcinoma: Phase III Findings on Pembrolizumab vs Observation
Clinical Trial Endpoints in the Adjuvant Setting for Renal Cell Carcinoma and Urothelial Cancer
The Dynamic Advancements in Personalized Treatments for Metastatic Urothelial Cancer
Immune Checkpoint Inhibitors Trials in Urothelial Cancer: Recent Updates and Future Outlook
Dr. Apolo on Side Effects of Cabozantinib Plus Immunotherapy Agents in Bladder Cancer